{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:41:59Z","timestamp":1792078919913,"version":"4.4.0"},"reference-count":40,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2019,9,17]]},"DOI":"10.3233\/jad-190546","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T11:32:24Z","timestamp":1565695944000},"page":"513-523","source":"Crossref","is-referenced-by-count":101,"title":["Efficacy and Safety of Cholinesterase Inhibitors for Mild Cognitive Impairment:A Systematic Review and Meta-Analysis"],"prefix":"10.1177","volume":"71","author":[{"given":"Shinji","family":"Matsunaga","sequence":"first","affiliation":[{"name":"Department of Geriatrics and Cognitive Disorders, Fujita Health University School of Medicine, Kutsukake, Toyoake, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshige","family":"Fujishiro","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Kawasaki Memorial Hospital, Miyamae, Kawasaki, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Takechi","sequence":"additional","affiliation":[{"name":"Department of Geriatrics and Cognitive Disorders, Fujita Health University School of Medicine, Kutsukake, Toyoake, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-190546_ref1","first-page":"411","article-title":"Mild cognitive impairment","volume":"19","author":"Lopez","year":"2013","journal-title":"Continuum (Minneap Minn)"},{"key":"10.3233\/JAD-190546_ref2","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.dadm.2019.01.004","article-title":"The incidence of mild cognitive impairment: A systematic review and data synthesis","volume":"11","author":"Gillis","year":"2019","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.3233\/JAD-190546_ref3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/cpt.1104","article-title":"Monotherapy is good enough for patients with mild-to-moderate Alzheimer\u2019s disease: A network meta-analysis of 76 randomized controlled trials","volume":"105","author":"Tsoi","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.3233\/JAD-190546_ref4","doi-asserted-by":"crossref","first-page":"805","DOI":"10.4103\/1673-5374.249228","article-title":"Comparative efficacy and safety of cognitive enhancers for treating vascular cognitive impairment: Systematic review and Bayesian network meta-analysis","volume":"14","author":"Jin","year":"2019","journal-title":"Neural Regen Res"},{"key":"10.3233\/JAD-190546_ref5","unstructured":"Matsunaga S , Kishi T , Yasue I , Iwata N (2015) Cholinesterase inhibitors for Lewy body disorders: A meta-analysis. Int J Neuropsychopharmacol 19, pyv086."},{"key":"10.3233\/JAD-190546_ref6","first-page":"CD009132","article-title":"Cholinesterase inhibitors for mild cognitive impairment","author":"Russ","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.3233\/JAD-190546_ref7","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1503\/cmaj.130451","article-title":"Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: A systematic review and meta-analysis","volume":"185","author":"Tricco","year":"2013","journal-title":"CMAJ"},{"key":"10.3233\/JAD-190546_ref8","first-page":"17","article-title":"Diagnosing and managing mild cognitive impairment","volume":"261","author":"Behrman","year":"2017","journal-title":"Practitioner"},{"key":"10.3233\/JAD-190546_ref9","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.3233\/JAD-190546_ref10","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A new rating scale for Alzheimer\u2019s disease","volume":"141","author":"Rosen","year":"1984","journal-title":"Am J Psychiatry"},{"key":"10.3233\/JAD-190546_ref11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.3233\/JAD-190546_ref12","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.3233\/JAD-190546_ref13","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): Current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"issue":"Suppl 2","key":"10.3233\/JAD-190546_ref14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00002093-199700112-00004","article-title":"Validity and reliability of the Alzheimer\u2019s Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer\u2019s Disease Cooperative Study.S","volume":"11","author":"Schneider","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-190546_ref15","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa050151","article-title":"Vitamin E and donepezil for the treatment of mild cognitive impairment","volume":"352","author":"Petersen","year":"2005","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"10.3233\/JAD-190546_ref16","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/00002093-199700112-00005","article-title":"An inventory to assess activities of daily living for clinical trials in Alzheimer\u2019s disease. The Alzheimer\u2019s Disease Cooperative Study.","volume":"11","author":"Galasko","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-190546_ref17","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"10.3233\/JAD-190546_ref18","unstructured":"Smith A (1982) Western Psychological Services, Los Angeles. Symbol digit modalities test (SDMT). Manual (revised).."},{"key":"10.3233\/JAD-190546_ref19","unstructured":"Lezak MD (1995), Neuropsychological assessment (3rd ed.) New York Oxford University Press."},{"key":"10.3233\/JAD-190546_ref20","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1176\/ajp.139.9.1136","article-title":"The Global Deterioration Scale for assessment of primary degenerative dementia","volume":"139","author":"Reisberg","year":"1982","journal-title":"Am J Psychiatry"},{"key":"10.3233\/JAD-190546_ref21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.3233\/JAD-190546_ref22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1600-0404.2009.01263.x","article-title":"A randomized controlled trial of rivastigmine in patients with cognitive impairment no dementia because of cerebrovascular disease","volume":"121","author":"Narasimhalu","year":"2010","journal-title":"Acta Neurol Scand"},{"key":"10.3233\/JAD-190546_ref23","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.jagp.2018.05.008","article-title":"Donepezil treatment in patients with depression and cognitive impairment on stable antidepressant treatment: A randomized controlled trial","volume":"26","author":"Devanand","year":"2018","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JAD-190546_ref24","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/01.wnl.0000344650.95823.03","article-title":"Donepezil treatment of patients with MCI: A 48-week randomized, placebo-controlled trial","volume":"72","author":"Doody","year":"2009","journal-title":"Neurology"},{"key":"10.3233\/JAD-190546_ref25","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.jalz.2014.10.003","article-title":"Donepezil decreases annual rate of hippocampal atrophy in suspected prodromal Alzheimer\u2019s disease","volume":"11","author":"Dubois","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-190546_ref26","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/ene.13872","article-title":"Donepezil for gait and falls in mild cognitive impairment: A randomized controlled trial","volume":"26","author":"Montero-Odasso","year":"2019","journal-title":"Eur J Neurol"},{"key":"10.3233\/JAD-190546_ref27","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1212\/01.WNL.0000134664.80320.92","article-title":"Efficacy of donepezil in mild cognitive impairment: A randomized placebo-controlled trial","volume":"63","author":"Salloway","year":"2004","journal-title":"Neurology"},{"key":"10.3233\/JAD-190546_ref28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/153331750502000502","article-title":"Effects of galantamine on working memory and global functioning in patients with mild cognitive impairment: A double-blind placebo-controlled study","volume":"20","author":"Koontz","year":"2005","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.3233\/JAD-190546_ref29","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s12603-012-0062-8","article-title":"A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI","volume":"16","author":"Peters","year":"2012","journal-title":"J Nutr Health Aging"},{"key":"10.3233\/JAD-190546_ref30","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1212\/01.wnl.0000303815.69777.26","article-title":"Safety and efficacy of galantamine in subjects with mild cognitive impairment","volume":"70","author":"Winblad","year":"2008","journal-title":"Neurology"},{"key":"10.3233\/JAD-190546_ref31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pscychresns.2016.01.018","article-title":"Effects of rivastigmine on visual attention in subjects with amnestic mild cognitive impairment: A serial functional MRI activation pilot-study","volume":"249","author":"Bokde","year":"2016","journal-title":"Psychiatry Res Neuroimaging"},{"key":"10.3233\/JAD-190546_ref32","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1474-4422(07)70109-6","article-title":"Effect of rivastigmine on delay to diagnosis of Alzheimer\u2019s disease from mild cognitive impairment: The InDDEx study","volume":"6","author":"Feldman","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-190546_ref33","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/mds.26236","article-title":"Rivastigmine for mild cognitive impairment in Parkinson disease: A placebo-controlled study","volume":"30","author":"Mamikonyan","year":"2015","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-190546_ref34","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1136\/jnnp-2016-313660","article-title":"Acetylcholinesterase inhibitors are associated with weight loss in older people with dementia: A systematic review and meta-analysis","volume":"87","author":"Soysal","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-190546_ref35","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/jgs.15069","article-title":"Comparative effectiveness and safety of cognitive enhancers for treating Alzheimer\u2019s disease: Systematic review and network metaanalysis","volume":"66","author":"Tricco","year":"2018","journal-title":"J Am Geriatr Soc"},{"key":"10.3233\/JAD-190546_ref36","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2174\/1567205012666150710111341","article-title":"Anti-dementia drugs-related changes in gait performance while single and dual tasking in patients with Alzheimer disease: A meta-analysis","volume":"12","author":"Beauchet","year":"2015","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-190546_ref37","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.nbd.2018.05.025","article-title":"Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer\u2019s Coordinating Center","volume":"117","author":"Hanfelt","year":"2018","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-190546_ref38","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1212\/WNL.0000000000004826","article-title":"Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology","volume":"90","author":"Petersen","year":"2018","journal-title":"Neurology"},{"key":"10.3233\/JAD-190546_ref39","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1017\/S031716710000216X","article-title":"Progress in clinical neurosciences: Treatment of Alzheimer\u2019s disease and other dementias\u2013review and comparison of the cholinesterase inhibitors","volume":"29","author":"Hogan","year":"2002","journal-title":"Can J Neurol Sci"},{"key":"10.3233\/JAD-190546_ref40","first-page":"MR000033","article-title":"Industry sponsorship and research outcome","volume":"2","author":"Lundh","year":"2017","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-190546","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:06:35Z","timestamp":1777370795000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-190546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,17]]},"references-count":40,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-190546","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,17]]}}}